Synthesis of [123I]‐3‐(4‐iodobenzyl)‐1,2,3,4‐tetrahydro‐8‐hydroxychromeno[3,4‐c]pyridin‐5‐one, a potential dopamine D4 ligand for SPECT studies
- 29 December 2004
- journal article
- Published by Wiley in Journal of Labelled Compounds and Radiopharmaceuticals
- Vol. 48 (2) , 101-108
Abstract
Schizophrenia is a devastating mental disorder characterized by relapsing psychotic episodes accompanied with emotional, professional and social decline. The classical dopamine hypothesis of schizophrenia postulates that hyperactivity of dopaminergic neurotransmission is responsible for the positive symptoms of the disorder, more exactly hyperactivity of the dopamine D2‐like receptors. One of these receptors is the D4 receptor which is thought to be involved in the motor side‐effects caused antipsychotics. However, research into the specific role of this receptor has been hampered by the lack of specific ligands. Therefore, a new 123I‐labelled compound was developed which may allow in vivo visualization of the D4 receptor by SPECT. [123I]‐3‐(4‐iodobenzyl)‐1,2,3,4‐tetrahydro‐8‐hydroxychromeno[3,4‐c]pyridin‐5‐one was prepared by electrophillic aromatic substitution of the tributylstannyl derivative. The radiochemical yield was 68±3% (n=5) and the specific activity was >2.96 Ci/µmol. Copyright © 2005 John Wiley & Sons, Ltd.Keywords
This publication has 11 references indexed in Scilit:
- Dopamine D2 and D4 receptor ligands: relation to antipsychotic actionEuropean Journal of Pharmacology, 1998
- Antipsychotic drugs which elicit little or no Parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptorsMolecular Psychiatry, 1998
- Chromeno[3,4-c]pyridin-5-ones: Selective Human Dopamine D4 Receptor Antagonists as Potential Antipsychotic AgentsJournal of Medicinal Chemistry, 1997
- Schizophrenia: elevation of dopamine D4-like sites, using [3H]nemonapride and [125I]epideprideEuropean Journal of Pharmacology, 1995
- Absence of detectable striatal dopamine D4 receptors in drug-treated schizophreniaEuropean Journal of Pharmacology, 1995
- Are Striatal Dopamine D4 Receptors Increased in Schizophrenia?Journal of Neurochemistry, 1994
- Dopamine D4 receptors elevated in schizophreniaNature, 1993
- Positron Emission Tomographic Analysis of Central D1 and D2 Dopamine Receptor Occupancy in Patients Treated With Classical Neuroleptics and ClozapineArchives of General Psychiatry, 1992
- Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapineNature, 1991
- Antipsychotic Drugs: Direct Correlation Between Clinical Potency and Presynaptic Action on Dopamine NeuronsScience, 1975